Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Med Mycol ; 58(7): 859-866, 2020 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-32030418

RESUMO

An increased prevalence of various filamentous fungi in sputum samples of patients with cystic fibrosis (CF) has been reported. The clinical significance, however, is mostly unclear. The aim of this study was to investigate the clinical relevance of Scedosporium spp. and Exophiala dermatitidis from sputum samples of patients with CF in the Netherlands. In this cross-sectional study, all CF patients of the Dutch national CF registry who were treated at five of the seven recognized CF centers during a 3-year period were included. We linked clinical data of the national CF registry with the national Dutch filamentous fungal database. We investigated the association between clinical characteristics and a positive sputum sample for Scedosporium spp. and E. dermatitidis, using logistic regression. Positive cultures for fungi were obtained from 3787 sputum samples from 699 of the 1312 patients with CF. Scedosporium spp. was associated with severe genotype, CF-related diabetes, several microorganisms, and inhaled antibiotics. E. dermatitidis was associated with older age, female sex, and Aspergillus spp. CF patients with and without Scedosporium spp. or E. dermatitidis seemed comparable in body mass index and lung function. This study suggests that Scedosporium spp. and E. dermatitidis are probably no major pathogens in CF patients in the Netherlands. Greater understanding of epidemiologic trends, risk factors, and pathogenicity of filamentous fungi in the respiratory tracts of patients with CF is needed.


Assuntos
Fibrose Cística/complicações , Fibrose Cística/microbiologia , Exophiala/isolamento & purificação , Infecções Fúngicas Invasivas/diagnóstico , Feoifomicose/diagnóstico , Scedosporium/isolamento & purificação , Escarro/microbiologia , Adolescente , Adulto , Criança , Estudos Transversais , Fibrose Cística/epidemiologia , Feminino , Humanos , Infecções Fúngicas Invasivas/etiologia , Masculino , Países Baixos/epidemiologia , Feoifomicose/etiologia , Prevalência , Adulto Jovem
2.
Rev Sci Instrum ; 89(12): 124706, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30599610

RESUMO

The performance of a reversible helical electromagnetic launcher (RHEML) is reported and discussed. The results demonstrate the feasibility of using the RHEML as an electrically programmable shock tester (EPST). The data show that the reversible helical electromagnetic launcher can be operated with parallel-connected armatures that share current and force. This report is also the first-ever successful demonstration of iron-cored HEML stators. The electrical programmability of the EPST has been demonstrated by varying the shock pulse width in approximately 30 ms increments. The armature assembly has a total mass of approximately 25 kg (55 lbs). The stators are approximately 100 mm (4 in.) in diameter and 2.3 m (90 in.) long. The large mass reversible helical electromagnetic launcher is powered by a 1 MJ capacitive pulse forming network. The armature assembly has a measured minimum velocity of 0.4 m/s and a maximum velocity of 8.3 m/s. The minimum acceleration/deceleration force is 4.3 gees, while the maximum acceleration/deceleration force is 30.7 gees. The minimum shock pulse width is 16 ms, and the maximum shock pulse width is 150 ms.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...